Abstract:Aims: CD36 , an important gene involved in cholesterol and fatty acid metabolism,, has been associated with many metabolic-related traits, including diabetes, hypertension, and obesity in different populations. However, the association of this gene with metabolic syndrome (MS) has not been well-studied. We aimed to investigate the association of CD36 with the risk of MS and longitudinal changes of its components in among participants of the Rural Chinese Cohort Study (RCCS). Materials and Methods: The RCCS enrolled 20,194 participants aged 2 18 years old between July of 2007 and August of 2008. A total of 17,265 participants (response rate 85.5%) were examined in the follow-up survey between July of 2013 and October of 2014. During the six years, 729 new incident cases of MS were ascertained. We conducted a nested case-control study within the RCCS. Specifically, 408 MS randomly cases and 408 one-to-one matched controls were included in the current study. In addition to follow-up time, non-MS controls were matched to MS cases on age, gender, marital status, and residence village. Human genomic DNA was extracted using a standard method from blood samples collected at the baseline. After quality control, 4 single nucleotide polymorphisms (SNPs) within the CD36 were successfully genotyped. MS was defined according to the 2009 criteria proposed by IDF and AHA/NHLBI. Multivariate conditional logistic regression was used to determine additive associations of SNPs and SNP-haplotype with MS adjusting for body mass index (BMI), smoking, drinking, and physical activity at baseline. Multivariate linear regression models were conducted among the control group to examine association of SNPs and SNP-haplotypes with MS components, controlling for age, gender, BMI, smoking, drinking and physical activity. Multiple testing was corrected by false positive discovery rate (FDR) method. Results: Two SNPs, rs7755 and rs1049673, were associated with risk for MS. Per minor allele increase in rs7755 and rs1049673 was associated with 2.29 (95% confidence interval [CI]: 1.24-4.24, p =0.008) and 2.30 (95% CI: 1.24-4.26, p =0.008) times higher odds of MS, respectively. In addition, rs1194197 was associated with changes of triglycerides level (β=0.151, p =0.014), and rs7755 (β=-0.065, p =0.028) and rs1049673 (β=-0.067, p =0.025) were associated with changes of high density lipoprotein cholesterol in the control group. One haplotype of the four SNPs, AGAG, was associated with the change of waist circumference (β=-1.773, p =0.048). Conclusions: We identified important SNPs and SNP-haplotypes of the CD36 associated with MS and changes of MS components in a Han Chinese population.

Metabolic syndrome in heart transplant recipients: prevalence and risk factors (a retrospective study)

Metabolic Syndrome in Liver Transplant Recipients:Prevalence and Risk Factors

Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?

Impact of metabolic syndrome on quality of life of liver transplant recipients

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.

Study on risk factors for new onset diabetes mellitus post orthotopic heart transplant (PTDM) and the relationship between PTDM and long-term survival

Cardiovascular effects of metabolic syndrome after transplantation: convergence of obesity and transplant-related factors

De Novo Metabolic Syndrome 1 Year after Liver Transplantation and Its Association with Mid- and Long-Term Morbidity and Mortality in Liver Recipients

Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study

Factors Predicting New-Onset Diabetes Mellitus And Metabolic Syndrome After Allogeneic Stem Cell Transplantation: Implication For Early Preventive Intervention

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Incidence of new-onset diabetes and posttransplant metabolic syndrome after liver transplantation - A prospective Study From South India

The interaction of T2DM and BMI with NASH in recipients of liver transplants: an SRTR database analysis

Abstract P114: Genetic Polymorphisms of CD36 Associated with Metabolic Syndrome in Chinese Han Population: A Nested Case-Control Study

Meta-Analysis of the Effects of Exercise Training on Markers of Metabolic Syndrome in Solid Organ Transplant Recipients.

Current Situation of Heart Transplantation:Chinese Heart Transplant Annual Report 2013

Postoperative cognitive dysfunction in heart transplantation recipients

Association of Abdominal Aortic Calcification With the Postoperative Metabolic Syndrome Components After Liver Transplantation

An Analysis on the Prevalence and Risk Factors of Post-Transplant Diabetes Mellitus after Renal Transplantation

Incidence, risk factors and clinical outcome of multidrug-resistant organisms after heart transplantation

Effect of Obesity and Metabolic Health Status on Metabolic-Associated Steatotic Liver Disease among Renal Transplant Recipients Using Hepatic Steatosis Index